Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

[Classification, staging and prognostic indices for multiple myeloma].

Tomomitsu Hotta¹

¹National Hospital Organization, Nagoya Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|December 12, 2007

Summary

Monoclonal gammopathies, including symptomatic myeloma, are diagnosed using new criteria involving M-protein, bone marrow plasmacytosis, and end-organ damage. Prognosis is estimated using staging systems like ISS and Durie/Salmon plus, aiding in better patient management.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Japanese journal of clinical oncology·2025

Same author

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.

Annals of hematology·2024

Same author

Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.

Cancer science·2023

Same author

A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.

Journal of clinical and experimental hematopathology : JCEH·2022

Same author

A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma.

Journal of clinical and experimental hematopathology : JCEH·2021

Same author

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A.

Journal of clinical and experimental hematopathology : JCEH·2021

Area of Science:

Hematology
Oncology

Context:

Monoclonal gammopathies encompass heterogeneous plasma cell disorders.
The International Myeloma Working Group (IMWG) established new diagnostic criteria.

Purpose:

To outline the diagnostic criteria for symptomatic myeloma.
To describe prognostic staging systems for monoclonal gammopathies.

Summary:

Symptomatic myeloma diagnosis requires M-protein in serum/urine, bone marrow plasmacytosis, and end-organ damage.
The International Staging System (ISS) uses serum beta-2 microglobulin and albumin.
The Durie/Salmon plus system incorporates PET/MRI imaging for prognosis.

Impact:

Facilitates standardized diagnosis of monoclonal gammopathies.

Related Experiment Videos

Last Updated: Jul 9, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Improves prognostic assessment through established staging systems.

Aids in defining prognosis for better patient care and treatment strategies.